Skip to content

Feasibility of Uninterrupted Infant Respiratory Support Treatment

Feasibility of Respiratory Management of Infants Needing Positive Pressure Ventilation or CPAP, Using a Single System to Deliver Uninterrupted Support Directly at Birth and the First Hours of Life

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04244890
Acronym
FUIRST
Enrollment
32
Registered
2020-01-28
Start date
2020-02-21
Completion date
2023-02-01
Last updated
2023-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Newborn, Respiratory Distress Syndrome, Newborn, Respiratory Insufficiency Syndrome of Newborn

Keywords

Continuous Positive Airway Pressure, Resuscitation

Brief summary

Feasibility study of a simplified respiratory support system for newborn infants

Detailed description

The study is a proof-of-concept feasibility trial that evaluates usage of a simplified respiratory support system for newborn infants. The study aims to evaluate both the feasibility of providing uninterrupted support for the first hours of life as well as a modified respiratory support system. The system is a modified version of the commercially available rPAP system. The revised design has a simplified gas supply and allows elimination of a complicated driver. The new system has low resistance to breathing equal to the rPAP system. The study will recruit 40-60 infants in a single centre without a comparison arm. The trial is conducted as a first step towards a large randomised trial.

Interventions

DEVICEUninterrupted CPAP for the first hours of life

Directly at birth the infant will be supported with PPV with PEEP as needed, followed by nasal CPAP. Support will be provided with a single device for up to four hours.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Vaginal delivery at gestational age between 28+0 and 34+6 * Caesarean section at gestational age between 28+0 and 37+6 * Infants in need of respiratory support in delivery-room

Exclusion criteria

* Carciac malformations * Airway malformations * Known syndromes or neuromuscular disorders * Transfer to other hospital within 4 hours likely

Design outcomes

Primary

MeasureTime frameDescription
Number of interruptions in CPAP treatment0-240 minutesNumber of CPAP-support interruptions (n)
Duration of interruptions in CPAP treatment0-240 minutesDuration CPAP support interruptions (min)
Cause of each interruption in CPAP treatment0-240 minutesReported reason for interruptions in CPAP treatment (free text as reported by staff)

Secondary

MeasureTime frameDescription
Level of respiratory support0-240 minutesWhat level of respiratory support was required? (Need for PPV, FiO2 and CPAP level)
Response to respiratory support0-240 minutesHow did the infant respond to the given respiratory support? (SpO2, PaCO2, Temperature)
Ease of use: Respiratory support system set up0-10 minutesHow easy was the system to set up? (Easy/Minor problems/Major difficulties)
Rare events in clinical management0-240 minutesDid any infant need chest compression, intubation or any other rare interventions?
Adverse events and safety0-240 minutesWas there any suspected or confirmed adverse events related to equipment or the research protocol?
Respiratory support at 48 hours0-240 minutesWhat respiratory support did the infant receive at 48 hours of age
Ease of use: Airway and respiratory supportmanagement0-60 minutesHow easy was airway and respiratory support management with the new system? (Easy/Minor problems/Major difficulties)
Ease of use: Fixation and transport0-60 minutesHow easy was fixation and transport from the delivery room? (Easy/Minor problems/Major difficulties)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026